Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Small Cell Lung Cancer That Has Relapsed or Not Responded to Treatment

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2013 by University of Nebraska
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Apar Kishor Ganti, MD, University of Nebraska
ClinicalTrials.gov Identifier:
NCT00856037
First received: March 4, 2009
Last updated: October 8, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)